LexDanaLexDanabeta
Inventor

Dilhumar UYGHUR

Inventor
JP

Overview

3→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes13%
C07BGeneral methods of organic chemistry13%
PatentTitleYear
12,091,410Heterocyclic compound202412,071,434Heterocyclic compound202411,655,241Heterocyclic compound and use thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to TAKEDA PHARMACEUTICALS CO (3)· patent assignee history
2023–2024Based in JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
TAKEDA PHARMACEUTICALS CO32023–2024
Locations
LocationPatentsSpan
JP32023–2024